Whole-genome Cancer Treatment Intelligence Platform
C2i Genomics empowers researchers, physicians, and patients with ultra-sensitive whole-genome cancer detection. Its SaaS solution utilizes a cloud-based platform to perform cancer tumor burden monitoring on a global scale, leveraging the thousands of already installed genome sequencers around the world. Using scientific breakthroughs, growing genomic and cl…